COVID-19

FDA ends pause on J&J vaccine

County health to resume administering their stockpile of the vaccines.

Federal health officials have recommended the resumption of the use of a COVID-19 vaccine produced by Johnson & Johnson. They had previously paused that recommendation while they investigated rare instances of blood clots in female patients.

Ultimately, scientific advisers determined the benefits of the vaccine outweighed the risks – though the vaccine will now come with a warning to young women about the risk of blood clots.

Sign up for our daily newsletter

A weekday morning email roundup of Kalamazoo stories and events.

Health departments around west Michigan are expected to resume the use of the vaccine. According to WWMT, Kalamazoo County’s Department of Health and Community Services said it would begin administering J&J vaccines as soon as the Centers for Disease Control and Prevention gave it the go-ahead.

The J&J vaccine is an important addition to the fight against COVID-19 for several reasons. It’s the only vaccine currently approved in the U.S. that requires only one dose to reach full effectiveness. That makes it especially useful for people who may not be likely to return for a second shot – for example, homeless communities.

It also doesn’t have the strict cold storage requirements of the other two vaccines, making it easier for smaller and more rural vaccine providers to keep and administer.

You can read more here.

Support local. Donate today to Kalamazoo's only locally owned and independent daily news organization.